| Application no. and date | 21191931.1 (espacenet) (Federated) (European Patent Register), 20170512 | | Patent/reg. no. and date | DK/EP 3932951, 20221207 | | Publication date | 20220105 | | Priority no. and date | US 201662335743 P, 20160513, US 201662340142 P, 20160523, US 201662348546 P, 20160610, US 201662350305 P, 20160615, US 201662364920 P, 20160721, US 201662374020 P, 20160812, US 201762451274 P, 20170127 | | EP pub. no. and date |
EP 3932951 20220105 | | Effective date | | | Applicant/owner | Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road
Tarrytown, NY 10591, US | | Applicant ref. no. | V455012DK00 | | Inventor | LOWY, Israel,
New York 10591, US,
FURY, Matthew, G.,
New York 10591, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61N 5/00 (2006.01) , A61N 5/10 (2006.01) , C07K 16/28 (2006.01) | | Title | Fremgangsmåder til behandling af hudcancer ved administration af en PD-1-hæmmer | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Rettet DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
